Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil

The symptoms of Alzheimer’s disease (AD) do not include only memory loss and cognitive decline but also neuropsychiatric manifestation. These AD-related symptoms are usually treated with the aid of antipsychotics; however, their effects on cognition and safety remain unexplored. The present study de...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Enzyme Inhib Med Chem
Päätekijät: Sikora, Joanna, Podsiedlik, Maria, Pietras, Tadeusz, Kosmalski, Marcin, Matłoka, Mikołaj, Moszczyński-Petkowski, Rafał, Wieczorek, Maciej, Markowicz-Piasecka, Magdalena
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534323/
https://ncbi.nlm.nih.gov/pubmed/32938236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14756366.2020.1818739
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia